DTL
QNCX icon

Dynamic Technology Lab’s Quince Therapeutics QNCX Stock Holding History

Dynamic Technology Lab’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31
Closed -$285K – 1278
2020
Q2 		$285K Buy
+31
New +$284K 0.04% 689

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's QNCX Position: Q3 2020 in Review

Dynamic Technology Lab sold out of Quince Therapeutics (QNCX) in Q3 2020, closing a stake of 31 shares — an estimated $285K sold.

Dynamic Technology Lab first reported a position in QNCX in Q2 2020 and held it in 1 quarter. The position peaked at $285K in Q2 2020. 79 funds tracked by Wall St. Rank hold QNCX as of Q3 2020.

  • Dynamic Technology Lab reported no remaining Quince Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Dynamic Technology Lab sold 31 Quince Therapeutics shares in Q3 2020, an estimated $285K.
  • Dynamic Technology Lab first reported a position in Quince Therapeutics in Q2 2020 and held it in 1 quarter.
  • Dynamic Technology Lab's Quince Therapeutics position peaked at $285K in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Quince Therapeutics as of Q3 2020.

Based on Dynamic Technology Lab's 13F filing for Q3 2020, filed 13 Nov 2020.